Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Taiwan

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Huang, Yen Chu ^a,b   Fan, Jun Yu ^c   Ro, Long Sun ^a,b   Lyu, Rong Kuo ^a,b   Chang, Hong Shiu ^a,b   Chen, Sien Tsong ^a,b   Hsu, Wen Chuin ^a,b   Chen, Chiung Mei ^a,b   Wu, Yih Ru ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; CHINESE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EMOTIONALITY; FEMALE; HEMIFACIAL SPASM; HFS 36; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT MOBILITY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; SOCIAL SUPPORT; STIGMA; TAIWAN; VALIDATION PROCESS; CLASSIFICATION; INSTRUMENTATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; PUBLICATION; REPRODUCIBILITY; VALIDATION STUDY;

ACTIVITIES OF DAILY LIVING; ADULT; BOTULINUM TOXINS; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TAIWAN; TRANSLATIONS;

EID: 75649092937     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-104     Document Type: Article

References (10)

1. Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 2002, 59:418-420. 10.1001/archneur.59.3.418, 11890846.
2. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998, 64:751-757. 10.1136/jnnp.64.6.751, 2170133, 9647304.
3. Meyers AR, Gage H, Hendricks A. Health-related quality of life in neurology. Arch Neurol 2000, 57:1224-1227. 10.1001/archneur.57.8.1224, 10927808.
4. Reimer J, Gilg K, Karow A, Esser J, Franke GH. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 2005, 111:64-70. 10.1111/j.1600-0404.2004.00357.x, 15595940.
5. Tan EK, Fook-Chong S, Lum SY, Lim E. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 2004, 219:151-155. 10.1016/j.jns.2004.01.010, 15050451.
6. Tan EK, Fook-Chong S, Lum SY, Thumboo J. Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36. J Neurol Neurosurg Psychiatry 2005, 76:1707-1710. 10.1136/jnnp.2005.065656, 1739450, 16291898.
7. Heuser K, Kerty E, Eide PK, Cvancarova M, Dietrichs E. Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality. Eur J Neurol 2007, 14:335-340.
8. Ware JE. SF-36 health survey update. Spine 2000, 25:3130-3139. 10.1097/00007632-200012150-00008, 11124729.
9. Tseng HM, Lu JFR, Tsai YJ. Assessment of Health Related Quality of Life (II): Norming and Validation of SF-36 Taiwan Version. Taiwan Journal of Public Health 2003, 22:512-518.
10. McGraw KO, Wong SP. Forming Inferences About Some Intraclass Correlation Coefficients. Psychological Methods 1996, 1:30-46.